Has anyone done BITE immunotherapy? If so what was it like? The chemo is done and lymphoma is already back five...

LymphomaNovember 7, 2026Written by Navis AI

BiTE Immunotherapy for Relapsed Lymphoma

I'm sorry to hear your lymphoma has returned so quickly after chemotherapy. That must be incredibly frustrating and concerning. Let me address both your questions about BiTE therapy and cardiac considerations.

1) BiTE Immunotherapy Experience

What BiTE Therapy Is: BiTE stands for "Bispecific T-cell Engager" - these are bispecific antibodies that simultaneously bind to CD20 (a protein on lymphoma cells) and CD3 (a protein on your T-cells). This creates a bridge that redirects your own immune system's T-cells to attack the cancer cells directly.

FDA-Approved BiTE Options for Lymphoma: According to NCCN Guidelines, there are currently three BiTE therapies approved for B-cell lymphomas:

  • Epcoritamab-bysp (Epkinly)
  • Mosunetuzumab-axgb (Lunsumio)
  • Glofitamab-gxbm (Columvi)

What Treatment Is Like: BiTE therapies are given as subcutaneous injections (under the skin) or IV infusions, typically in cycles. The treatment schedule varies by specific drug but generally involves:

  • Step-up dosing initially to reduce side effects
  • Regular administration (weekly or every few weeks)
  • Outpatient treatment in most cases
  • Monitoring for cytokine release syndrome (CRS), especially with early doses

Common Side Effects:

  • Cytokine release syndrome (fever, low blood pressure, fatigue) - usually mild with step-up dosing
  • Injection site reactions
  • Fatigue
  • Infections (due to low white blood cell counts)
  • Neurological effects (less common than with CAR-T)

Cardiac Considerations: This is particularly relevant given your heart concerns. BiTE therapies generally have lower cardiac risk than CAR-T because:

  • No chemotherapy conditioning required (unlike CAR-T)
  • Lower rates of severe cytokine release syndrome
  • No lymphodepletion chemotherapy needed
  • Can be stopped if side effects occur (unlike CAR-T where cells are permanently in your body)

According to NCCN Guidelines for Marginal Zone Lymphomas, "Bispecific antibody therapy is an option after HCT or CAR T-cell therapy" - and importantly, it can be used when CAR-T isn't suitable.

Tell us what’s going on with lymphoma. 2 free answers, then a free account.

2) Cardiac Health and Treatment Options

Why This Matters for You: Your cardiac issues are an important factor in treatment selection. The NCCN Guidelines acknowledge that treatment decisions should be individualized based on your overall health status.

Questions to Ask Your Oncologist:

  1. Which BiTE therapy do you recommend for my specific lymphoma subtype, and why?
  2. What cardiac monitoring will be done during BiTE treatment?
  3. How does my specific heart condition affect my treatment options?
  4. What is the step-up dosing protocol to minimize cytokine release syndrome?
  5. Are there other treatment options besides BiTE and CAR-T that might work for my situation? (such as other targeted therapies, different chemotherapy regimens, or clinical trials)
  6. What are the expected response rates for BiTE therapy in early relapsed lymphoma like mine?
  7. If BiTE therapy doesn't work, what would be the next treatment approach?

Other Considerations: Given your early relapse (5 weeks post-chemo), your oncologist may also consider:

  • Clinical trials - NCCN strongly recommends clinical trial participation when available
  • Alternative systemic therapies - depending on what you received initially
  • Radiation therapy - for localized disease
  • Combination approaches - BiTE therapy with other agents

Important Context: The NCCN Guidelines note that "the order of treatment matters" - some therapies can't be used after others. Since you're avoiding CAR-T due to cardiac issues, BiTE therapy preserves future treatment options and doesn't close doors the way some other treatments might.

Summary

Strong Evidence Coverage:

  • ✅ BiTE immunotherapy options and mechanisms well-documented in NCCN Guidelines
  • ✅ Treatment approaches for relapsed lymphoma clearly outlined
  • ✅ Cardiac considerations acknowledged in treatment selection

Limited Coverage:

  • ⚠️ Patient experience stories with BiTE therapy (this is newer, so fewer patient testimonials available)
  • ⚠️ Specific cardiac risk data for BiTE vs. CAR-T (would benefit from cardio-oncology consultation)

Next Steps:

  1. Request urgent oncology consultation given your early relapse
  2. Ask for cardio-oncology evaluation to formally assess which treatments are safest for your heart
  3. Inquire about clinical trials - you may have access to newer therapies
  4. Get a second opinion if you're not confident in your current treatment plan

Your situation - early relapse with cardiac contraindications to CAR-T - is exactly the scenario where BiTE therapy can be valuable. However, your oncologist will need to determine the most appropriate approach based on your complete clinical picture, including your specific lymphoma subtype, prior treatments, and cardiac status.


This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

Your next question, already answered

Tap to keep going. 2 free answers, then a free account.

Ask Navis about your case

That answer is general. Ask about your specific situation. Answered right here.

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Sources & medical oversight

Question asked:

Has anyone done BITE immunotherapy? If so what was it like? The chemo is done and lymphoma is already back five weeks later. I won't do car-t due to heart issues. I appreciate any advice.

Facing this with someone you love?

Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.

Start a care circle →

More questions about Lymphoma